Molecular Partners AG
MOLN
$3.77
-$0.20-5.04%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -12.79M | -18.97M | -16.68M | -12.95M | -22.34M |
Total Depreciation and Amortization | 443.00K | 683.30K | 666.80K | 692.00K | 350.10K |
Total Amortization of Deferred Charges | 206.10K | -- | -- | -- | 329.80K |
Total Other Non-Cash Items | -4.18M | 3.51M | 422.40K | -4.03M | 4.98M |
Change in Net Operating Assets | 1.30M | -588.50K | -1.80M | -3.20M | -1.38M |
Cash from Operations | -15.03M | -15.36M | -17.39M | -19.50M | -18.06M |
Capital Expenditure | -154.90K | -297.10K | -210.10K | -139.50K | -336.50K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -4.96M | 16.74M | 14.75M | 20.28M | 22.31M |
Cash from Investing | -5.12M | 16.44M | 14.54M | 20.14M | 21.97M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -303.00K | -302.00K | -302.00K | -301.00K | -300.00K |
Issuance of Common Stock | 17.35M | 1.00K | 35.00K | 1.00K | 2.00K |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -1.74M | -- | -- | -- | -- |
Cash from Financing | 17.42M | -348.00K | -295.30K | -343.10K | -336.50K |
Foreign Exchange rate Adjustments | 580.70K | -660.20K | 200.20K | 885.20K | -4.81M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -2.14M | 76.30K | -2.94M | 1.18M | -1.23M |